Join to View Full Profile
Marietta Rheumatology Associates670 North Avenue Suite 100Marietta, GA 30060
Phone+1 770-590-8328
Fax+1 770-590-8231
Dr. Querubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Roel Querubin, MD is an Internal Medicine specialist with a subspecialty in Rheumatology based in Dobbins Afb, GA. His medical education includes a residency in Internal Medicine at Wellstar Health System/Wellstar Atlanta Medical Center and a fellowship in Rheumatology at Emory University School of Medicine. In addition, he graduated with honors from Georgia Institute of Technology with a Bachelors of Science in Applied Biology. Dr. Querubin is experienced in treating conditions such as systemic lupus erythematosus, sjogren's syndrome, vasculitides, inflammatory myopathies, and arthritis. He has published work in J Clin Rheumatol and participated in several clinical trials primarily related to Axial Spondyloarthritis. He was also recognized with the CMS Meaningful Use Stage 1 Certification from eClinicalWorks EHR in 2012-2013.
Education & Training
Emory University School of MedicineFellowship, Rheumatology, 1998 - 2000
Wellstar Health System/Wellstar Cobb HospitalResidency, Internal Medicine, 1995 - 1998
Medical College of Georgia at Augusta UniversityClass of 1995- Georgia Institute of TechnologyBachelors of Science, Applied Biology, Honors Graduate, 1987 - 1991
Certifications & Licensure
CA State Medical License 2000 - Present
GA State Medical License 1997 - 2025
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
- A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
- A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTemporal arteritis in a patient with eosinophilia.R Querubin, M Abubaker, Bruce A. Koplan, C A Agudelo
Journal of Clinical Rheumatology. 2000-02-01
Press Mentions
Sorrento to Host Webcast to Discuss Newly Presented Clinical Data Demonstrating Significant Improvements in Therapeutic Outcomes in 10 of 10 Patients with Poorly Controlled Rheumatoid ArthritisNovember 13th, 2022
Professional Memberships
- Member
- Clinical Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
